[Management of pediatric status epilepticus]

Revista Medica De Chile
|March 22, 2016
PubMed

Insights

Pediatric status epilepticus (SE), a medical emergency, now has a 5-minute seizure duration criterion. Early, aggressive management is crucial for better outcomes in children with SE.

Area of Science:

  • Pediatric Neurology
  • Emergency Medicine
  • Epileptology

Background:

  • Pediatric Status Epilepticus (SE) presents a significant risk of morbidity and mortality.
  • Current understanding necessitates early and aggressive intervention for improved patient outcomes.
  • The definition of SE has evolved, with a reduced time criterion to 5 minutes.

Purpose of the Study:

  • To review and update concepts, pathophysiology, and etiology of convulsive SE in pediatrics.
  • To provide an overview of available antiepileptic treatments for pediatric SE.
  • To propose a rational management scheme for pediatric SE.

Main Methods:

  • A comprehensive literature search was conducted for articles published between January 1993 and January 2013.
  • The search focused specifically on the pediatric population.
  • Evidence synthesis from case series, primarily adult data, was used due to limited pediatric-specific research.

Main Results:

  • The definition of SE was updated to a minimum of 5 minutes of continuous or recurrent seizures without consciousness recovery.
  • Refractory SE is defined as SE persisting beyond 60-120 minutes, requiring anesthetic management.
  • Super-refractory SE involves a lack of response to or relapse during anesthetic withdrawal.
  • Reported outcomes include 35% mortality, 26% neurological sequelae, and 35% recovery to baseline.

Conclusions:

  • Evidence for pediatric SE management is limited, often extrapolated from adult studies.
  • Treatment alternatives like immunotherapy, ketogenic diet, surgery, and hypothermia are discussed.
  • A structured management approach is essential for optimizing care in pediatric SE.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.6K
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.3K
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
2.1K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
369
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
756
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
2.2K